Monday, August 20, 2018
 
 
Company News: Page (1) of 1 - 05/16/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Blavatnik Family Foundation Provides $10 Million Gift to Mount Sinai to Support Mission of Advancing Women’s Health
 
(May 16, 2018)
Blavatnik Family Foundation Provides $10 Million Gift to Mount Sinai to Support Mission of Advancing Women’s Health

Emily and Len Blavatnik, whose significant philanthropic giving through the Blavatnik Family Foundation focuses on scientific research, higher education, and the arts, have made a $10 million gift to the Mount Sinai Health System. The gift establishes The Blavatnik Family Women's Health Research Institute at the Icahn School of Medicine at Mount Sinai and The Blavatnik Family – Chelsea Medical Center at Mount Sinai, located at 325 West 15th Street in the Chelsea neighborhood of New York City.

“Len and Emily are long-time advocates for women's health whose generous philanthropic commitment will significantly strengthen Mount Sinai's research program while positioning us as a leader in the field," said Michael L. Brodman, MD, Professor and Chair, Ellen and Howard C. Katz Chairman's Chair, Department of Obstetrics, Gynecology, and Reproductive Science, Mount Sinai Health System.

Elizabeth Howell, MD, MPP, will be the founding Director of The Blavatnik Family Women's Health Research Institute. Dr. Howell, who is also Vice Chair of Research and Professor of Obstetrics, Gynecology, and Reproductive Science and of Population Health Science and Policy at the Icahn School of Medicine, said the Institute's first areas of focus will be ovarian and endometrial cancers, postpartum depression, pregnancy-related deaths, and severe maternal complications-health conditions affecting one out of every three to four women in the United States.



“This is a critical time for women's health research," said Dr. Howell. “While a number of clinical centers exist for women's health, few centers are aimed at advancing science in women's health. We will aim to find solutions to common women's health problems, close gaps in quality of care that exist for underserved populations, and improve the health and well-being of women in New York City and beyond."

The Blavatnik Family – Chelsea Medical Center at Mount Sinai serves as the clinical bridge to The Blavatnik Family Women's Health Research Institute by offering a full range of health services with the comfort and intimacy of a neighborhood doctor's office located in the heart of Chelsea. Through the Women's Cancer Program, also located in The Blavatnik Family – Chelsea Medical Center at Mount Sinai, patients are offered a highly specialized medical team with individualized and compassionate care. Patients are also able to receive onsite tests, procedures, imaging, radiation, and infusion treatments such as chemotherapy, as well as wellness and support services that includes working individually with social workers and nutritionists.

“Len and I are proud to support this new and innovative initiative," said Mrs. Blavatnik. “We look forward to following the ever-increasing synergy between the new Research Institute and the expanded Medical Center, bringing scientific discoveries in women's health directly to patients who will benefit most."

"We are deeply grateful for the Blavatniks' immense generosity, which will help to enhance Mount Sinai's reputation as one of the world's leaders in women's health and train the next generation of scientific leaders," said Kenneth L. Davis, MD, President and CEO of the Mount Sinai Health System.

About the Blavatnik Family Foundation
The Blavatnik Family Foundation is an active supporter of leading educational, scientific, cultural, and charitable institutions in the United States, Europe, and throughout the world. The Foundation is headed by Len Blavatnik, an American industrialist and philanthropist. Mr. Blavatnik is the founder and Chairman of Access Industries, a privately-held U.S. industrial group with global interests in natural resources and chemicals, media and telecommunications, venture capital, and real estate. For more detailed information, please visit http://www.accessindustries.com.

About the Mount Sinai Health System
The Mount Sinai Health System is New York City's largest integrated delivery system encompassing seven hospital campuses, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai's vision is to produce the safest care, the highest quality, the highest satisfaction, the best access and the best value of any health system in the nation. The System includes approximately 7,100 primary and specialty care physicians; 10 joint-venture ambulatory surgery centers; more than 140 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and 31 affiliated community health centers. Physicians are affiliated with the renowned Icahn School of Medicine at Mount Sinai, which is ranked among the highest in the nation in National Institutes of Health funding per investigator. The Mount Sinai Hospital is ranked No. 18 on U.S. News & World Report's “Honor Roll" of top U.S. hospitals; it is one of the nation's top 20 hospitals in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Geriatrics, Nephrology, and Neurology/Neurosurgery, and in the top 50 in four other specialties in the 2017-2018 “Best Hospitals" issue. Mount Sinai's Kravis Children's Hospital also is ranked in six out of ten pediatric specialties by U.S. News & World Report. The New York Eye and Ear Infirmary of Mount Sinai is ranked 12th nationally for Ophthalmology and 50th for Ear, Nose, and Throat, while Mount Sinai Beth Israel, Mount Sinai St. Luke's and Mount Sinai West are ranked regionally. For more information, visit http://www.mountsinai.org/, or find Mount Sinai on Facebook, Twitter, and YouTube.

Read the full story at http://www.prweb.com/releases/2018/05/prweb15495830.htm.


Page: 1


Related Keywords:
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Neurovascular Devices Market High Revenue at USD 24,650 mn by 2023 | Therapeutic Application Hemorrhagic & Ischemic Strokes | Worldwide Segmentation by MRFR
  • Global Hemodialysis and Peritoneal Dialysis Market to Witness a CAGR of 5.9% during 2018-2024
  • The Alzheimer's Research and Prevention Foundation (ARPF) Announces Second Brain Longevity® Therapy Training Program in Washington D.C.
  • Image Guided Radiotherapy Market to Experience Unfaltering Growth at 15.8% CAGR to Revolutionize the Healthcare Sector by 2023
  • Disposable Negative Pressure Wound Therapy Devices Market: Global Industry Analysis (2012 - 2016) & Opportunity Assessment (2017 - 2027)

    Cancer
  • Information Update - Teva Canada expands recall of valsartan drugs to include additional lots, as a precaution
  • Singapore's first clinical trial approval for T cell engineered (TCR) immunotherapy for treatment of Liver cancer
  • ViewRay Announces Full Exercise of Underwriters' Option to Purchase Additional Shares and Closing of Public Offering of Common Stock
  • Mirati Therapeutics Announces Presentation Of KRAS G12C Chemistry Advances At The 255th American Chemical Society (ACS) National Meeting And Exposition
  • Agenus Receives Second Milestone Payment from Merck
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines